Tarsus Pharmaceuticals News

Barclays Maintains Tarsus Pharmaceuticals(TARS.US) With Buy Rating, Maintains Target Price $60

Moomoo NewsJul 25 05:34 ET

Tarsus Pharmaceuticals Analyst Ratings

BenzingaMay 10 15:18 ET

Analysts Offer Insights on Healthcare Companies: Tarsus Pharmaceuticals (TARS), Collegium Pharmaceutical (COLL) and Intellia Therapeutics (NTLA)

TipRanksMay 10 05:15 ET

Tarsus Pharmaceuticals Analyst Ratings

BenzingaMay 9 12:46 ET

Oppenheimer Adjusts Tarsus Pharmaceuticals Price Target to $61 From $59, Maintains Outperform Rating

MT NewswiresMay 9 11:21 ET

Tarsus Pharmaceuticals Analyst Ratings

BenzingaFeb 28 07:47 ET

Analysts Offer Insights on Healthcare Companies: Irhythm Technologies (IRTC), Tarsus Pharmaceuticals (TARS) and Springworks Therapeutics (SWTX)

TipRanksFeb 28 05:50 ET

Goldman Sachs Initiates Coverage On Tarsus Pharmaceuticals With Neutral Rating, Announces Price Target of $19

BenzingaNov 20, 2023 04:43 ET

Tarsus Pharmaceuticals Analyst Ratings

BenzingaNov 20, 2023 04:41 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Knight Therapeutics (OtherKHTRF), Tarsus Pharmaceuticals (TARS) and Illumina (ILMN)

TipRanksNov 10, 2023 10:20 ET

Tarsus Pharmaceuticals Analyst Ratings

BenzingaNov 10, 2023 07:43 ET

Analysts Conflicted on These Healthcare Names: Nurix Therapeutics (NRIX), Tarsus Pharmaceuticals (TARS) and TG Therapeutics (TGTX)

TipRanksOct 16, 2023 06:31 ET

Guggenheim Maintains Buy on Tarsus Pharmaceuticals, Raises Price Target to $49

BenzingaSep 11, 2023 09:52 ET

Tarsus Pharmaceuticals Analyst Ratings

BenzingaSep 11, 2023 09:51 ET

Tarsus Pharmaceuticals Analyst Ratings

BenzingaAug 14, 2023 08:37 ET

HC Wainwright & Co. Maintains Buy on Tarsus Pharmaceuticals, Lowers Price Target to $42

BenzingaAug 11, 2023 06:26 ET

Tarsus Pharmaceuticals Analyst Ratings

BenzingaAug 11, 2023 06:25 ET

HC Wainwright Adjusts Price Target on Tarsus Pharmaceuticals to $50 From $44, Maintains Buy Rating

MT NewswiresJul 26, 2023 09:48 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Tarsus Pharmaceuticals (TARS), Kiniksa Pharmaceuticals (KNSA) and Danaher (DHR)

TipRanksJul 26, 2023 06:41 ET

HC Wainwright & Co. Maintains Buy on Tarsus Pharmaceuticals, Raises Price Target to $50

BenzingaJul 26, 2023 06:10 ET